|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8 EUR | -2.44% |
|
+76.60% | -90.17% |
| Apr. 24 | Transcript : Vivoryon Therapeutics N.V., 2023 Earnings Call, Apr 24, 2024 | |
| Mar. 15 | Vivoryon Therapeutics N.V Announces Resignation of Board of Directors | CI |
Vivoryon Therapeutics N.V. approved the appointment of Frank Weber, MD, and Anne Doering, CFA, to the Company's Board as executive directors.
| 1st Jan change | Capi. | |
|---|---|---|
| -90.17% | 22.26M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
VIVORYON THERAPEUTICS N.V. 
